Detecting when the most common skin cancer turns dangerous
A biomarker associated with basal cell carcinoma may help signal which tumors will be more aggressive, a new U-M study finds.
Apr 20, 2016
0
1
A biomarker associated with basal cell carcinoma may help signal which tumors will be more aggressive, a new U-M study finds.
Apr 20, 2016
0
1
(HealthDay)—There is considerable interpersonal and intrapersonal agreement on the presence of basal cell carcinoma (BCC) on Mohs slides, according to a study published online April 1 in the British Journal of Dermatology.
Apr 7, 2016
0
1
An article in the journal Cell by top scientists from the Translational Genomics Research Institute (TGen) and Mayo Clinic in Arizona details how two relatively new drugs are helping patients with basal cell carcinoma.
Mar 31, 2016
0
0
The skin cancer called basal cell carcinoma (BCC) is one of the most common types of cancer. 90 per cent of the population are at risk to develop it one day, notably because of their age and exposure to the sun UV-rays. Although ...
Mar 7, 2016
0
1
(HealthDay)—Intralesional cryosurgery is feasible for treating basal cell carcinoma (BCC) of the lower extremities in elderly patients, according to a study published in the March issue of the International Journal of Dermatology.
Feb 23, 2016
0
1
Prices among 19 brand-name prescription dermatologic drugs increased rapidly between 2009 and 2015, with prices for topical antineoplastic drugs to prevent the spread of cancer cells increasing an average of 1,240 percent, ...
Nov 25, 2015
0
0
(HealthDay)—Late age at natural menopause and menopausal hormone therapy (MHT) use are associated with increased risk of basal cell carcinoma (BCC), according to a study published online Nov. 2 in the Journal of Clinical ...
Nov 3, 2015
0
26
(HealthDay)—A case of basal cell carcinoma (BCC) has been described within a port wine stain (PWS), with no preceding treatment, according to a case report published in the October issue of The Journal of Dermatology.
Oct 26, 2015
0
4
Current drugs may stop working against the most common type of brain tumor in children, medulloblastoma, but the tumor could be targeted in a new way, according to Stanford University scientists.
Sep 15, 2015
0
15
(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation.
Jul 25, 2015
0
12